Benchmark Success, Clinical Failure: When Reinforcement Learning Optimizes for Benchmarks, Not Patients

Abstract: Recent Reinforcement Learning (RL) advances for LLMs have improved reasoning tasks, yet their resource-constrained application to medical imaging remains underexplored. We introduce ChexReason, a vision-LLM trained via R1-style methodology (SFT followed by GRPO) using only 2,000 SFT samples, 1,000 RL samples, and a single A100 GPU. Evaluations on CheXpert and NIH benchmarks reveal a fundamental tension: GRPO recovers in-distribution performance (23% improvement on CheXpert, macro-F1 = 0.346) but degrades cross-dataset transferability (19% drop on NIH). This mirrors high-resource models like NV-Reason-CXR-3B, suggesting the issue stems from the RL paradigm rather than scale. We identify a generalization paradox where the SFT checkpoint uniquely improves on NIH before optimization, indicating teacher-guided reasoning captures more institution-agnostic features. Furthermore, cross-model comparisons show structured reasoning scaffolds benefit general-purpose VLMs but offer minimal gain for medically pre-trained models. Consequently, curated supervised fine-tuning may outperform aggressive RL for clinical deployment requiring robustness across diverse populations.